The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the What's New section. Go check it out! Check out the Communication page for a complete list of forms or by clicking the link: Communications
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...